latest news in companies

Tow.Market Launches AI Marketplace to Modernize Roadside Assistance

Tow.Market Launches AI Marketplace to Modernize Roadside Assistance

New York, Monday, 12 January 2026.
Valued at $15 million, Tow.Market officially launched its “Uber-like” AI platform today, aiming to digitize the fragmented towing industry through real-time dispatch and transparent pricing.

Trump Signals Intent to Exclude ExxonMobil from Venezuela Following CEO's Skepticism

Trump Signals Intent to Exclude ExxonMobil from Venezuela Following CEO's Skepticism

Washington D.C., Monday, 12 January 2026.
Labeling ExxonMobil’s caution as “playing too cute,” President Trump signaled plans to bar the energy giant from Venezuela after CEO Darren Woods deemed the current legal framework “uninvestable.”

Avatar: Fire and Ash Retains Top Box Office Spot for Fourth Consecutive Weekend

Avatar: Fire and Ash Retains Top Box Office Spot for Fourth Consecutive Weekend

Los Angeles, Monday, 12 January 2026.
James Cameron’s sequel generated $21.3 million domestically, becoming the first film since Barbie to lead for four straight weekends, driving global earnings past $1.23 billion.

Faraday Future Confirms February Robotics Launch in 2026 Strategic Outlook

Faraday Future Confirms February Robotics Launch in 2026 Strategic Outlook

Los Angeles, Monday, 12 January 2026.
On February 4, Faraday Future expands beyond electric vehicles, launching its first AI robotics products at the NADA Show to drive its ambitious dual-growth strategy for 2026.

Beam Therapeutics Secures FDA Pathway for Accelerated Genetic Liver Disease Treatment

Beam Therapeutics Secures FDA Pathway for Accelerated Genetic Liver Disease Treatment

Cambridge, Sunday, 11 January 2026.
Beam Therapeutics reached a pivotal FDA agreement allowing biomarker-based accelerated approval for its genetic liver treatment, significantly de-risking its pipeline while extending cash operations into 2029.

Day One Biopharmaceuticals Posts Triple-Digit Revenue Growth Driven by Cancer Drug Success

Day One Biopharmaceuticals Posts Triple-Digit Revenue Growth Driven by Cancer Drug Success

Brisbane, Sunday, 11 January 2026.
Preliminary data reveals a 172% revenue surge for Day One’s cancer therapy, setting a bullish foundation for projected 2026 sales topping $225 million.

Kura Oncology Shares Early Commercial Results for Leukemia Treatment

Kura Oncology Shares Early Commercial Results for Leukemia Treatment

San Diego, Sunday, 11 January 2026.
Kura Oncology generated $2.1 million in initial sales for its newly approved leukemia drug, supporting a robust $667 million cash position as the company targets 2026 expansion.

Anthropic and HealthEx Partner to Bring AI Analysis to Personal Medical Records

Anthropic and HealthEx Partner to Bring AI Analysis to Personal Medical Records

San Francisco, Sunday, 11 January 2026.
Anthropic’s new partnership with HealthEx allows users to securely analyze personal data from over 50,000 healthcare providers, transforming scattered records into actionable insights via private AI conversations.

Teva Secures $500 Million Partnership to Accelerate New Vitiligo Therapy

Teva Secures $500 Million Partnership to Accelerate New Vitiligo Therapy

Tel Aviv, Sunday, 11 January 2026.
Royalty Pharma commits up to $500 million to fast-track Teva’s immune-regulating antibody, explicitly targeting a 2026 start for Phase 2b trials to treat vitiligo patients.

Fox Sports Reschedules IndyCar Ad Debut for NFL Divisional Playoffs

Fox Sports Reschedules IndyCar Ad Debut for NFL Divisional Playoffs

Los Angeles, Sunday, 11 January 2026.
Fox Sports has strategically adjusted the launch of its marquee IndyCar promotional campaign, moving the debut from the NFL Wild Card weekend to the Divisional Round games scheduled for the weekend of January 17, 2026. While initial industry reports anticipated a launch during the January 10-11 matchups, the network—a subsidiary of Fox Corporation (FOXA)—opted to delay the driver-focused commercials. This scheduling shift positions the racing series’ exposure alongside higher-stakes NFL content, potentially maximizing viewer engagement during a more decisive phase of the playoffs. The revised timeline underscores the network’s calculated approach to leveraging its premium football broadcasting rights to effectively cross-promote the IndyCar property to a broader sports audience.